JPWO2019178296A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019178296A5 JPWO2019178296A5 JP2020548709A JP2020548709A JPWO2019178296A5 JP WO2019178296 A5 JPWO2019178296 A5 JP WO2019178296A5 JP 2020548709 A JP2020548709 A JP 2020548709A JP 2020548709 A JP2020548709 A JP 2020548709A JP WO2019178296 A5 JPWO2019178296 A5 JP WO2019178296A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell
- reprogramming
- aged
- aging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023172587A JP2024016026A (ja) | 2018-03-13 | 2023-10-04 | 細胞加齢の反転のための一過性細胞リプログラミング |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862642538P | 2018-03-13 | 2018-03-13 | |
| US62/642,538 | 2018-03-13 | ||
| PCT/US2019/022149 WO2019178296A1 (fr) | 2018-03-13 | 2019-03-13 | Reprogrammation cellulaire transitoire d'inversion du vieillissement cellulaire |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023172587A Division JP2024016026A (ja) | 2018-03-13 | 2023-10-04 | 細胞加齢の反転のための一過性細胞リプログラミング |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021518331A JP2021518331A (ja) | 2021-08-02 |
| JPWO2019178296A5 true JPWO2019178296A5 (fr) | 2023-03-02 |
Family
ID=67907311
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020548709A Pending JP2021518331A (ja) | 2018-03-13 | 2019-03-13 | 細胞加齢の反転のための一過性細胞リプログラミング |
| JP2023172587A Pending JP2024016026A (ja) | 2018-03-13 | 2023-10-04 | 細胞加齢の反転のための一過性細胞リプログラミング |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023172587A Pending JP2024016026A (ja) | 2018-03-13 | 2023-10-04 | 細胞加齢の反転のための一過性細胞リプログラミング |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20210010034A1 (fr) |
| EP (1) | EP3764795A4 (fr) |
| JP (2) | JP2021518331A (fr) |
| KR (1) | KR20200131301A (fr) |
| CN (1) | CN112154210A (fr) |
| AU (1) | AU2019235861A1 (fr) |
| BR (1) | BR112020018602A2 (fr) |
| CA (1) | CA3093823A1 (fr) |
| CR (1) | CR20200462A (fr) |
| IL (1) | IL277265A (fr) |
| MX (1) | MX2020009491A (fr) |
| SG (1) | SG11202008839WA (fr) |
| WO (1) | WO2019178296A1 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230091910A1 (en) * | 2019-04-02 | 2023-03-23 | Centagen, Inc. | Engineered System of Stem Cell Rejuvenation to Treat Aging and Disease |
| US11359011B2 (en) | 2019-08-07 | 2022-06-14 | Edifice Health, Inc. | Treatment and prevention of cardiovascular disease |
| TWI789724B (zh) * | 2020-03-20 | 2023-01-11 | 台灣粒線體應用技術股份有限公司 | 粒線體用於治療及/或預防肌腱受損或其相關疾病之用途 |
| WO2021211382A1 (fr) * | 2020-04-13 | 2021-10-21 | Edifice Health, Inc. | Composés et procédés de modification de l'iage |
| EP4251742A1 (fr) * | 2020-11-24 | 2023-10-04 | Lyell Immunopharma, Inc. | Procédés de fabrication, compositions comprenant, et procédés d'utilisation de lymphocytes t régénérés |
| US20230042860A1 (en) | 2021-07-15 | 2023-02-09 | Turn Biotechnologies, Inc. | Polycistronic expression vectors |
| CN116334002A (zh) * | 2021-10-14 | 2023-06-27 | 北京干细胞与再生医学研究院 | 年轻化骨骼肌肉细胞及其制备方法和应用 |
| WO2023201097A1 (fr) | 2022-04-15 | 2023-10-19 | Turn Biotechnologies, Inc. | Procédés et compositions pour le rajeunissement et les thérapies de cellules immunitaires à l'aide de cellules immunitaires régénérées |
| WO2023215857A2 (fr) * | 2022-05-06 | 2023-11-09 | President And Fellows Of Harvard College | Traitements pour un dysfonctionnement cellulaire lié à l'âge |
| WO2024012503A1 (fr) * | 2022-07-12 | 2024-01-18 | 南京瑞初医药有限公司 | Composition et sa méthode d'utilisation |
| WO2024012502A1 (fr) * | 2022-07-12 | 2024-01-18 | 南京瑞初医药有限公司 | Composition et son procédé d'utilisation |
| CN116426469B (zh) * | 2023-06-07 | 2023-09-08 | 北京大学口腔医学院 | LAP2α在间充质干细胞成脂向分化中的应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9012219B2 (en) * | 2005-08-23 | 2015-04-21 | The Trustees Of The University Of Pennsylvania | RNA preparations comprising purified modified RNA for reprogramming cells |
| PL2578685T3 (pl) * | 2005-08-23 | 2020-01-31 | The Trustees Of The University Of Pennsylvania | Rna zawierający zmodyfikowane nukleozydy i sposoby jego zastosowania |
| US8669048B2 (en) * | 2008-06-24 | 2014-03-11 | Parkinson's Institute | Pluripotent cell lines and methods of use thereof |
| KR102171849B1 (ko) * | 2009-12-07 | 2020-10-30 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 세포 리프로그래밍을 위한 정제된 변형 ｒｎａ를 포함하는 ｒｎａ 제제 |
| WO2011091048A1 (fr) * | 2010-01-19 | 2011-07-28 | The Board Of Trustees Of The Leland Stanford Junior University | Conversion directe de cellules en cellules d'autres lignées |
| WO2011094738A1 (fr) * | 2010-02-01 | 2011-08-04 | The Board Of Trustees Of The Leland Stanford Junior University | Efficacité améliorée de génération de cellules souches pluripotentes induites |
| ES2695550T3 (es) * | 2011-04-08 | 2019-01-09 | Inst Nat Sante Rech Med | Método para rejuvenecer células |
| US10155929B2 (en) * | 2012-05-13 | 2018-12-18 | Allele Biotechnology & Pharmaceuticals, Inc. | Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA |
| EP3104889B1 (fr) * | 2014-02-10 | 2021-10-13 | The Board of Trustees of the Leland Stanford Junior University | Activation de l'immunité innée pour améliorer la reprogrammation nucléaire de cellules somatiques avec un arnm |
| WO2016024101A1 (fr) * | 2014-08-13 | 2016-02-18 | Timmons James Archibald | Diagnostic médical |
| EP3242934B1 (fr) * | 2015-01-08 | 2021-08-18 | The Board of Trustees of the Leland Stanford Junior University | Facteurs et cellules pour l'induction d'os, de moelle osseuse et de cartilage |
| AU2016206649A1 (en) * | 2015-01-14 | 2017-08-03 | Memorial Sloan-Kettering Cancer Center | Age-modified cells and methods for making age-modified cells |
| EP3132809A1 (fr) * | 2015-08-21 | 2017-02-22 | Bioskinco GmbH | Composition et produits comprenant des cellules sénescentes pour une utilisation dans la régénération tissulaire |
| CA3087254A1 (fr) * | 2018-01-02 | 2019-07-11 | Khloris Biosciences, Inc. | Utilisation d'un vaccin a base d'ipsc en tant que traitement prophylactique et therapeutique du cancer |
| US20220162553A1 (en) * | 2019-02-15 | 2022-05-26 | The Board Of Trustees Of The Leland Stanford Junior University | Generation of type 1 regulatory t cells through transcription factor targeting |
| WO2020210202A1 (fr) * | 2019-04-11 | 2020-10-15 | The Board Of Trustees Of The Leland Stanford Junior University | Lymphocytes t cytotoxiques, spécifiques de formes mutées du récepteur du facteur de croissance épidermique, destinés à être utilisés dans le traitement du cancer |
| US20230045590A1 (en) * | 2019-12-23 | 2023-02-09 | The Board Of Trustees Of The Leland Stanford Junior University | Genetically corrected cells for therapeutic use |
-
2019
- 2019-03-13 BR BR112020018602-3A patent/BR112020018602A2/pt unknown
- 2019-03-13 AU AU2019235861A patent/AU2019235861A1/en active Pending
- 2019-03-13 SG SG11202008839WA patent/SG11202008839WA/en unknown
- 2019-03-13 JP JP2020548709A patent/JP2021518331A/ja active Pending
- 2019-03-13 CR CR20200462A patent/CR20200462A/es unknown
- 2019-03-13 KR KR1020207029373A patent/KR20200131301A/ko unknown
- 2019-03-13 WO PCT/US2019/022149 patent/WO2019178296A1/fr unknown
- 2019-03-13 CN CN201980031919.8A patent/CN112154210A/zh active Pending
- 2019-03-13 EP EP19768132.3A patent/EP3764795A4/fr active Pending
- 2019-03-13 US US16/979,842 patent/US20210010034A1/en active Pending
- 2019-03-13 CA CA3093823A patent/CA3093823A1/fr active Pending
- 2019-03-13 MX MX2020009491A patent/MX2020009491A/es unknown
-
2020
- 2020-09-10 IL IL277265A patent/IL277265A/en unknown
-
2023
- 2023-10-04 JP JP2023172587A patent/JP2024016026A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021518331A (ja) | 細胞加齢の反転のための一過性細胞リプログラミング | |
| AU2022200207B2 (en) | Compositions and methods for induced tissue regeneration in mammalian species | |
| CN104937095B (zh) | 肾细胞群及其用途 | |
| US20100135970A1 (en) | Methods for Reprogramming Adult Somatic Cells and Uses Thereof | |
| US20200199541A1 (en) | Blood vessel organoid, methods of producing and using said organoids | |
| CN102459576A (zh) | 用于调节干细胞的组合物和方法及其应用 | |
| JPWO2019178296A5 (fr) | ||
| EP3835413A1 (fr) | Procédé et composition pour favoriser la croissance cellulaire et la réparation tissulaire | |
| CN109152799A (zh) | 胰腺干细胞及其用途 | |
| Sarkar et al. | Transient non-integrative nuclear reprogramming promotes multifaceted reversal of aging in human cells | |
| RU2801316C2 (ru) | Транзиентное клеточное перепрограммирование для обращения старения клетки | |
| Kenigsberg et al. | Genome engineering of human urine-derived stem cells to express lactoferrin and deoxyribonuclease | |
| Shao et al. | Human muscle stem/progenitor cells are bi-potential adult stem cells | |
| Sarkar | Transient Reprogramming for Multifaceted Reversal of Aging Phenotypes | |
| US20110052551A1 (en) | Cardiac myocyte morphogenic compositions and methods of use therefor | |
| US20150056172A1 (en) | Methods and compositions using fgf-8 to enhance cardiac regeneration and attenuate adverse cardiac remodeling |